Trial document
DRKS00017275
Trial Description
Title
Impact of a Smartphone application (KAIA COPD-App) in combination with Activity Monitoring as maintenance program following pulmonary rehabilitation in COPD : an international multi-centered randomised controlled trial
Trial Acronym
KAIA COPD-001
URL of the Trial
[---]*
Brief Summary in Lay Language
The purpose of this study is to investigate how the use of a smartphone application (COPD-APP) in combination with activity monitoring in patients with chronic obstructive pulmonary disease (COPD) affects physical activity, quality of life, physical fitness, symptoms, feeling and health. For this, we compare people who carry out the program at home for half a year (training group) with persons who perform only an activity monitoring and regular tests (control group).
Brief Summary in Scientific Language
The overall objective is to assess the effectiveness of the newly developed COPD-App as a maintenance program after Pulmonary Rehabilitation.
The primary objective is to assess the clinical efficacy of the COPD-App maintenance program on physical activity measured in steps/d in patients with COPD after 6 months.
Secondary objectives are to evaluate the effects of the COPD-App-program on
• Functional exercise capacity.
• Health-related quality of life (HRQoL).
• Patient reported health status.
• Exacerbations and depression and anxiety symptoms.
Other Objectives : Further we aim to explore the patients’ compliance/adherence and safety, identify factors which facilitate the implementation of the program in the patient’s home setting and to evaluate factors of the program which are especially supportive for the patients.
Do you plan to share individual participant data with other researchers?
[---]*
Description IPD sharing plan:
[---]*
Organizational Data
- DRKS00017275
- 2019/06/27
- [---]*
- no
- Approved
- 2019-00766, Kantonale Ethikkomission Zürich
Secondary IDs
- [---]*
Health Condition or Problem studied
- J44 - Other chronic obstructive pulmonary disease
Interventions/Observational Groups
-
Device : KAIA COPD-App (Mobile Application).
The study intervention is an exercise training program that requires a chair and elastic bands, consisting of training elements with progressive levels of intensity, individually adaptable to the participant’s exercise level. This training program is delivered to the participants with the help of KAIA COPD-App. The individualized training sessions will last approximately 15-20 minutes and will be conducted by the participants seven days per week at home during six months of the trial period. - Training of the control-group is performed by regular recommendations during the study period.
Characteristics
- Interventional
- [---]*
- Randomized controlled trial
- Open (masking not used)
- [---]*
- Active control (effective treament of control group)
- Treatment
- Parallel
- N/A
- N/A
Primary Outcome
The primary outcome is the change in physical activity of the intervention group in comparison to the control group, measured over one week as mean steps per day comparing baseline to 6 months visit value.
Secondary Outcome
Secondary outcomes assessed are :
• dyspnea (COPD-Assessment test (CAT))
• functional exercise capacity (1-minute Sit-to stand test)
• HRQoL (Chronic respiratory disease questionere, CRQ)
• health status (Feeling Thermometer)
• HADS (Anxiety and depression scale)
• Number of exacerbations (Questionnaire as defined by GOLD Guidelines)
• Reaching his or her individual defined goal of physical activity
• Sleep efficiency and sleep quality
Countries of Recruitment
- Germany
- Switzerland
Locations of Recruitment
- Medical Center
- Medical Center
Recruitment
- Actual
- 2019/08/09
- 104
- Multicenter trial
- International
Inclusion Criteria
- Both, male and female
- 40 Years
- no maximum age
Additional Inclusion Criteria
• COPD Patients willing and able to sign informed consent for use of their pseudonymized clinical data within the scope of the present interventional trial
• COPD patients who have completed an in-hospital pulmonary rehabilitation program with an average duration of 3 weeks.
• Diagnosis of COPD, defined as forced expiratory volume in 1s/forced vital capacity (FEV1/FVC)<70% predicted, FEV1<80 % predicted after bronchodilation, with or without chronic symptoms (cough, sputum production) corresponding to a GOLD stage II-IV
• Completion of an inpatient pulmonary rehabilitation
• Completion of the screening period and fulfilling of the randomization criteria as defined by the protocol
• Ability to use a smartphone and smartphone-apps
• Willingness to wear an activity tracker during study period of 6 months
• Male and female patients between (Minimum age) and ≥40 years of age, Females of child bearing potential must have a negative pregnancy test prior to entry in the study
• Knowledge of German language to understand study material, assessments and contents of the COPD-App
Exclusion Criteria
• The Patient is not able to conduct the exercise training program due to physical, cognitive or safety reasons, as judged by investigator; e.g., lower limb joint surgery within preceding 3 months, unstable cardiac disease, predominant neurological limitations, planned surgical or other interventions disturbing the study intervention.
• Significant psychiatric disorders, legal incapacity or limited legal capacity.
• Patients participation in another clinical trial with an investigational medication within 30 days prior to study entry.
• Patients already using the KAIA COPD App
Addresses
-
start of 1:1-Block address primary-sponsor
- Kaia Health Software GmbH
- Mr. Dr. Stephan Huber
- Siegfriedstr. 8
- 80803 München
- Germany
end of 1:1-Block address primary-sponsorstart of 1:1-Block address contact primary-sponsor- +49-89-20207057
- [---]*
- stephan.huber at kaiahealth.com
- [---]*
end of 1:1-Block address contact primary-sponsor -
start of 1:1-Block address scientific-contact
- Zürcher RehaZentren Wald
- Mr. PD Dr. med. Marc Spielmanns
- Faltigbergstrasse 7
- 8636 Wald
- Switzerland
end of 1:1-Block address scientific-contactstart of 1:1-Block address contact scientific-contact- +41 55 256 68 00
- [---]*
- Marc.Spielmanns at zhreha.ch
- [---]*
end of 1:1-Block address contact scientific-contact -
start of 1:1-Block address public-contact
- Zürcher RehaZentren Wald
- Mr. PD Dr. med Marc Spielmanns
- Faltigbergstr. 7
- 8636 Wald
- Switzerland
end of 1:1-Block address public-contactstart of 1:1-Block address contact public-contact- +41 55 256 68 00
- [---]*
- Marc.Spielmanns at zhreha.ch
- [---]*
end of 1:1-Block address contact public-contact
Sources of Monetary or Material Support
-
start of 1:1-Block address materialSupport
- Kaia Health Software GmbH
- Siegfriedstr. 8
- 80803 München
- Germany
end of 1:1-Block address materialSupportstart of 1:1-Block address contact materialSupport- [---]*
- [---]*
- [---]*
- [---]*
end of 1:1-Block address contact materialSupport
Status
- Recruiting ongoing
- [---]*
Trial Publications, Results and other Documents
- [---]*